U.S. stocks move: 10x Genomics surged on October 9th due to target price upgrade, Fred Hutchinson collaboration, and spatial genomics.
Bitget异动解读2026/10/09 14:0510x Genomics October 9th Surge Analysis
Keywords: Target Price Raise, Fred Collaboration, Spatial Omics
1. On October 9th, BofA Securities raised the target price for 10x Genomics from $50 to $80 and maintained a hold rating.
2. On October 7th, the company reached a multi-project research collaboration with Fred Hutchinson Cancer Center, utilizing the Flex Apex, Xenium, and upcoming Atera platforms to conduct biomarker discovery in bladder cancer and minimal residual disease detection in acute myeloid leukemia, driving the application of single-cell and spatial technologies into clinical research of solid tumors and hematologic malignancies.
(Disclaimer: This content is generated by AI technology based on public information summary, for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delta Air Lines executive says the US economy remains very strong
Delta Air Lines (DAL.US) executives stated that the U.S. economy remains "very strong."
U.S. Stock Market Move: Oracle surges on October 9 due to OpenAI clarification, AI cloud, and tech rebound
Crypto prices
More
